Central Petroleum Ltd Stock
Price
Target price
€0.040
€0.040
0.000%
-
0.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Central
sharewise wants to provide you with the best news and tools for Central, so we directly link to the best financial data sources.
Financials
News
Alliance Entertainment Touts 21% Sales Jump, Collectibles Push at Investor Event
Key Points
- Interested in Alliance Entertainment Holding Corporation? Here are five stocks we like better.
- Alliance Entertainment reported strong quarterly growth, with revenue rising 21% year
West Bancorporation Q2 Earnings Call Highlights
Key Points
- Interested in West Bancorporation, Inc.? Here are five stocks we like better.
- West Bancorporation posted a strong second quarter, with net income rising to $11.1 million from $8
Airtel Africa Q1 Earnings Call Highlights
Key Points
- Interested in Airtel Africa Plc? Here are five stocks we like better.
- Revenue and subscriber growth remained strong in Q1 2027, with group revenue up more than 21% in constant
Banco Santander Q2 Earnings Call Highlights
Banco Santander (NYSE:SAN) reported what executives described as its strongest first half ever, with record quarterly profit in the
Mercantile Bank Q2 Earnings Call Highlights
Key Points
- Interested in Mercantile Bank Corporation? Here are five stocks we like better.
- Mercantile Bank reported higher Q2 2026 profit, with net income of $25.9 million, or $1.50 per
3M Q2 Earnings Call Highlights
Key Points
- Interested in 3M Company? Here are five stocks we like better.
- 3M beat second-quarter expectations with organic growth of 5.4%, adjusted EPS of $2.40, and free cash flow of $1.3
Franklin Covey Showcases ‘Presenting for Impact’ to Turn Messages Into Action
Key Points
- Interested in Franklin Covey Company? Here are five stocks we like better.
- Franklin Covey highlighted its “Presenting for Impact” program in a webinar, positioning it as a framework
Factorial Energy Eyes Solid-State Battery Scale-Up After Nasdaq Debut
Key Points
- Interested in Factorial Energy? Here are five stocks we like better.
- Factorial Energy says its Nasdaq debut is a milestone, but the real focus is execution: proving its solid-state
Watches of Switzerland Group Eyes U.S., Pre-Owned Growth as UK Stabilizes
Key Points
- Interested in Watches of Switzerland Group plc? Here are five stocks we like better.
- Watches of Switzerland is leaning hard into U.S. expansion, where sales reached $1.24 billion in
FB Financial Q2 Earnings Call Highlights
Key Points
- Interested in FB Financial Corporation? Here are five stocks we like better.
- FB Financial posted solid Q2 results with EPS of $1.13 and adjusted EPS of $1.14, while net income
TruBridge Stockholders Approve IKS Merger at Special Meeting
Key Points
- Interested in TruBridge, Inc.? Here are five stocks we like better.
- TruBridge stockholders approved the company’s merger agreement with Inventurus Knowledge Solutions Inc. (IKS)
argenx Eyes More VYVGART Growth as Pipeline Catalysts Near
Executives at argenex (NASDAQ:ARGX) told investors at a Goldman Sachs healthcare event that they continue to see meaningful growth opportunities for
SailPoint Q1 Earnings Call Highlights
Key Points
- Interested in SailPoint, Inc.? Here are five stocks we like better.
- SailPoint posted a strong Q1 with annual recurring revenue of $1.163 billion, up 26% year over year, and revenue
Align Technology Pitches AI-Powered Digital Dentistry Platform Beyond Invisalign
Key Points
- Interested in Align Technology, Inc.? Here are five stocks we like better.
- Align Technology is repositioning itself as a broader digital dentistry platform, not just an Invisalign
Ollie's Bargain Outlet Q1 Earnings Call Highlights
Key Points
- Interested in Ollie's Bargain Outlet Holdings, Inc.? Here are five stocks we like better.
- Q1 results topped expectations with net sales up 14% to $659 million, comparable-store
Aveanna Healthcare Raises 2026 Outlook After Family First Deal, Eyes 7%-10% Growth
Key Points
- Interested in Aveanna Healthcare Holdings Inc.? Here are five stocks we like better.
- Aveanna raised its 2026 guidance after closing the Family First Homecare acquisition, now
Alarum Technologies Q1 Earnings Call Highlights
Key Points
- Interested in Alarum Technologies Ltd. Sponsored ADR? Here are five stocks we like better.
- Alarum Technologies reported Q1 2026 revenue of $11.7 million, up 64% year over year, with
IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing
Key Points
- Interested in IDEAYA Biosciences, Inc.? Here are five stocks we like better.
- Darovasertib, IDEAYA’s lead drug, posted strong Phase I/II results in first-line HLA-A2 negative
Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference
Key Points
- Interested in Gilead Sciences, Inc.? Here are five stocks we like better.
- Trodelvy is a key near-term catalyst for Gilead, with management highlighting upcoming data in first-line
Helical H2 Earnings Call Highlights
Key Points
- Interested in Helical plc? Here are five stocks we like better.
- Helical posted stronger earnings and net asset value, with EPRA profit doubling to GBP 5.5 million and EPRA NTA
Youdao Q1 Earnings Call Highlights
Key Points
- Interested in Youdao, Inc. Unsponsored ADR? Here are five stocks we like better.
- Revenue and profitability improved modestly in Q1 2026, with net revenue up 3.8% year over year to
The Sage Group H1 Earnings Call Highlights
The Sage Group (LON:SGE) reported what Chief Executive Officer Steve Hare called an “excellent first half” of fiscal 2026, citing broad-based double-digit revenue growth, margin expansion and
Mitchells & Butlers H1 Earnings Call Highlights
Mitchells & Butlers (LON:MAB) said first-half trading remained ahead of the wider market, with management pointing to resilient sales, cost controls and balance sheet progress despite weaker
Belite Bio Q1 Earnings Call Highlights
Key Points
- Interested in Belite Bio, Inc. Sponsored ADR? Here are five stocks we like better.
- Belite Bio said it has started a rolling NDA submission to the FDA for Tinlarebant in Stargardt
Alico Pitches Florida Land Pivot as Citrus Exit Unlocks Real Estate Value
Key Points
- Interested in Alico, Inc.? Here are five stocks we like better.
- Alico is exiting unprofitable citrus operations after two straight years of about $30 million in annual losses